Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance.

Kitange, Gaspar J; Carlson, Brett L; Schroeder, Mark A; Decker, Paul A; Morlan, Bruce W; Wu, Wenting; Ballman, Karla V; Giannini, Caterina; Sarkaria, Jann N

Kitange, Gaspar J; Carlson, Brett L; Schroeder, Mark A; Decker, Paul A; Morlan, Bruce W; Wu, Wenting; Ballman, Karla V; Giannini, Caterina; Sarkaria, Jann N.

Affiliation

Kitange GJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA. kitange.gaspar@mayo.edu

J Neurooncol ; 100(2): 177-86, 2010 Nov.

Article in En | MEDLINE | ID: mdl-20443131

Subject(s)

Antigens, Differentiation, B-Lymphocyte/biosynthesis; Brain Neoplasms/metabolism; Drug Resistance, Neoplasm/genetics; Glioma/metabolism; Histocompatibility Antigens Class II/biosynthesis; Animals; Antineoplastic Agents/pharmacology; Blotting, Western; Brain Neoplasms/genetics; Dacarbazine/analogs & derivatives; Dacarbazine/pharmacology; Gene Expression Profiling; Gene Knockdown Techniques; Glioma/genetics; Humans; Immunohistochemistry; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Temozolomide; Transfection; Xenograft Model Antitumor Assays

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antigens, Differentiation, B-Lymphocyte / Histocompatibility Antigens Class II / Drug Resistance, Neoplasm / Glioma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Neurooncol Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google